NEGX.F Stock Overview
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
NexgenRx Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.20 |
| 52 Week High | CA$0.21 |
| 52 Week Low | CA$0.18 |
| Beta | 0.23 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -46.11% |
| 5 Year Change | n/a |
| Change since IPO | 5.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEGX.F | US Insurance | US Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | 2.2% |
| 1Y | n/a | 22.5% | 22.8% |
Return vs Industry: Insufficient data to determine how NEGX.F performed against the US Insurance industry.
Return vs Market: Insufficient data to determine how NEGX.F performed against the US Market.
Price Volatility
| NEGX.F volatility | |
|---|---|
| NEGX.F Average Weekly Movement | n/a |
| Insurance Industry Average Movement | 4.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NEGX.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NEGX.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Ron Loucks | www.nexgenrx.com |
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
NexgenRx Inc. Fundamentals Summary
| NEGX.F fundamental statistics | |
|---|---|
| Market cap | US$11.42m |
| Earnings (TTM) | -US$242.98k |
| Revenue (TTM) | US$10.13m |
1.1x
P/S Ratio-47.0x
P/E RatioIs NEGX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEGX.F income statement (TTM) | |
|---|---|
| Revenue | CA$13.85m |
| Cost of Revenue | CA$3.03m |
| Gross Profit | CA$10.82m |
| Other Expenses | CA$11.15m |
| Earnings | -CA$331.97k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0047 |
| Gross Margin | 78.14% |
| Net Profit Margin | -2.40% |
| Debt/Equity Ratio | 0% |
How did NEGX.F perform over the long term?
See historical performance and comparison